Categories: New Launches

Vijyoti and TEM International enter exclusive alliance to introduce Patient Blood Management enabling technologies in India

New Delhi, April 05, 2016: Vijyoti, India’s leading corporate social enterprise with specialization in innovation management in the pharma and education sector has partnered with TEM International, a leading German medical technology company that is redefining bleeding control through its proprietary ROTEM® (Rotational Thromboelastometry) point-of-care diagnostic equipment to introduce cutting edge solutions for patient blood management in India.

ROTEM – The Optimal Haemostasis Analyser is the first choice solution for doctors globally in detecting, managing and monitoring haemostasis in cardiac surgery, liver transplant. obsetrics and trauma patients. The analyzer provides precise results within 5-10 minutes, whereas standard laboratory testing takes up to 40-60 minutes. The technology allows for targeted therapy to be provided at the point-of-care (POC).

Speaking on the occasion of India’s first National Symposium on Innovations in Bleeding Management, Dr. Klaus Goerlinger, Senior Consultant for Anaesthesiology, Intensive Care and Emergency Medicine, University Duisburg-Essen, Germany, said:. “Bleeding and blood transfusion have been shown to be independent risk factors for increased morbidity and mortality. Our collaboration with Vijyoti will help introduce ROTEM as an integral technology to patient blood management in India, one that will allow for point-of-care decisions for blood transfusion to be the last resort and not the first option to manage bleeding.”

Speaking on the occasion Mr. Vijay Pande, Managing Director, Vijyoti, said, “Despite being a country with a population of 1.2 billion, India faces a blood shortage of three million units annually. Patient blood management demands a change in the mindset towards bleeding management. Entering into the healthcare segment through our alliance with TEM International, Vijyoti is immensely honoured to introduce ROTEM to India and promote blood conservation with benefit to the patient, the blood banks and hospitals by enabling efficient and economical use of this increasingly scarce, expensive resource.”

ROTEM conducts four tests simultaneously – EXTEM, INTEM, FIBTEM and APTEM/HEPTEM. The easy-to-use portable device comes with a powerful intuitive software package and a sophisticated data handling system. The database stores all results and can be easily exported into MS Excel or other software for further processing.

Corporate Comm India (CCI Newswire)

The Pharma Times News Bureau

Recent Posts

8 Ways Insomnia Affects Skin Health & How To Avoid It

By Dr. Priyanka Kuri, Consultant - Dermatology, Aster Whitefield Hospital, Bengaluru Insomnia, the persistent inability…

4 days ago

Breaking New Ground in Migraine Care: A Landmark Session on Diagnosis and Treatment

Illuminating Latest Advances in Migraine Diagnosis and Treatment New Delhi, December 21, 2024: In a…

4 days ago

Healthcare Startups to Watch Out for in 2025

New Delhi, December 20, 2024: The healthcare sector is undergoing a transformation fueled by technological…

5 days ago

DKMS’s First Global Impact Report of 2023 Serves as New Ray of Hope for Blood Cancer Patients Worldwide

National, December 20, 2024: DKMS just published its first Global Impact Report that outlines the organization's…

5 days ago

Sterling Biotech to start world’s first precision fermentation-based dairy protein factory in Gujarat

Ahmedabad, December 19, 2024: Sterling Biotech Limited, a joint venture between Perfect Day and Zydus, has…

6 days ago

Pioneers in Senior Care, Antara, Partners with Leading Diagnostics Player Dr. Lal PathLabs to Strengthen its Geriatric Care Services

New Delhi, December 19, 2024: Antara Senior Care, an integrated eco-system provider for lifestyle and…

6 days ago